ClinicalTrials.Veeva

Menu

The Prognostic Role of Tricuspid Annular Plane Systolic Excursion in Critically Ill Patients With Septic Shock

A

Alexandria University

Status

Completed

Conditions

Septic Shock

Treatments

Radiation: tricuspid annular plane systolic excursion (TAPSE)

Study type

Observational

Funder types

Other

Identifiers

NCT06008067
TAPSESEPTIC

Details and patient eligibility

About

The aim of this study is to evaluate the possible prognostic performance of RV dysfunction, as assessed by TAPSE, in non-cardiac patients with septic shock.

Full description

The objective is to investigate the prognostic performance of right ventricular dysfunction, as assessed by tricuspid annular plane systolic excursion (TAPSE), in non-cardiac patients with septic shock.

Enrollment

100 patients

Sex

All

Ages

18 to 64 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients (18 - 64 years old) with septic shock after admission according to 2016 consensus definition (Sepsis-3).

Exclusion criteria

  • Pregnant females
  • Trauma
  • Documented coronary heart disease
  • History of myocardial infarction
  • Myocarditis
  • Thrombo-embolic pulmonary disease
  • Valvular heart disease
  • Corpulmonale
  • Arrhythmia
  • Known left ventricular ejection fraction < 40%
  • Poor echocardiographic window

Trial design

100 participants in 2 patient groups

Survivors
Description:
Patients who survived after day 28.
Treatment:
Radiation: tricuspid annular plane systolic excursion (TAPSE)
Non-survivors
Description:
Patients who died at or before day 28.
Treatment:
Radiation: tricuspid annular plane systolic excursion (TAPSE)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems